Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Affymetrix Inc.

Facebook Twitter LinkedIn Email Comments
Affymetrix Inc. of Santa Clara and NuGen Technologies Inc. of San Carlos, both in California, have announced an agreement to market the NuGen WT-Ovation FFPE system, enabling global gene expression analyses on archives of small and degraded formalin-fixed, paraffin-embedded (FFPE) samples using standard Affymetrix GeneChip 3' expression arrays.

In other news, Affymetrix’s Clinical Services Laboratory in West Sacramento has been granted California’s Clinical Laboratory Improvement Amendments certification. The lab offers microarray-based molecular diagnostic patient and clinical trial testing for the development of personalized tests and therapies. Based on standardized guidelines, the certification validates the lab’s methods with regard to accuracy, precision, sensitivity, calibration, control and repeatability.

Jun 2007
Affymetrix Inc.Biophotonicsexpression arraysmicroarray-based molecular diagnosticNews & Features

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.